Open Access
Subscription or Fee Access
A narrative review on cardiovascular disease due to the role of deficiency of Vitamin D and its management
Abstract
Cardiovascular disease is the prevalent cause of morbidity and mortality in the world, affecting many millions of individuals every year. Atherosclerosis, a chronic inflammatory condition that involves different cell types, several cytokines and adhesion molecules, is the underlying cause of cardiovascular disease. Vitamin D plays a pivotal role in bone homeostasis and calcium metabolism. Though, current research has specified additional helpful effects of vitamin D on the cardiovascular system. Vitamin D shortage is connected with chronic inflammatory diseases, counting diabetes and obesity both being strong risk issues for cardiovascular diseases (CVD). CVD, counting myocardial infarction, coronary artery disease, cardiomyopathy, hypertrophy, cardiac fibrosis, stroke, aneurysm, heart failure, peripheral arterial disease, hypertension, and atherosclerosis, are chief reasons of morbidity and mortality worldwide. The objective of this study is to review vitamin D’s pathophysiology, describe its relationship with cardiovascular diseases based on the most recent publications, and highlight the results of vitamin D supplementation in the prevention of such causes.
Keywords
References
Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, Perel P, Mensah GA, Narula J, Johnson CO, Roth GA. Global Atlas of Cardiovascular Disease. Global heart. 2018;13(3).
Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Frontiers in immunology. 2018 Sep 6;9:2031.
Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S, Kosmas CE. Inflammation in coronary artery disease. Cardiology in review. 2014 Nov 1;22(6):279-88.
Suades R, Padro T, Vilahur G, Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thrombosis and haemostasis. 2012;108(12):1208-19.
Badimon L, Suades R, Arderiu G, Peña E, Chiva-Blanch G, Padró T. Microvesicles in atherosclerosis and angiogenesis: from bench to bedside and reverse. Frontiers in cardiovascular medicine. 2017 Dec 18;4:77.
Quyyumi AA, Patel RS. Endothelial dysfunction and hypertension: cause or effect?.
Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007 Jul 19;357(3):266-81.
Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002 May 1;30(5):771-7.
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of internal medicine. 2008 Jun 9;168(11):1174-80.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Archives of internal medicine. 2008 Jun 23;168(12):1340-9.
Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of internal medicine. 2007 Jun 11;167(11):1159-65.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. British Journal of Nutrition. 2003 May;89(5):552-72.
Kimlin MG. Geographic location and vitamin D synthesis. Molecular aspects of medicine. 2008 Dec 1;29(6):453-61.
Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. The American journal of clinical nutrition. 2004 Mar 1;79(3):362-71.
Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis-associated heart failure.
Zittermann A, Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Current opinion in clinical nutrition & metabolic care. 2008 Nov 1;11(6):752-7.
Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Molecular and cellular endocrinology. 2004 Feb 27;215(1-2):31-8.
Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology. 2008 Feb 1;149(2):558-64.
Mancuso P, Rahman A, Hershey SD, Dandu L, Nibbelink KA, Simpson RU. 1, 25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. Journal of cardiovascular pharmacology. 2008 Jun 1;51(6):559-64.
Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. The Journal of steroid biochemistry and molecular biology. 2007 Mar 1;103(3-5):416-9.
Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU. 1, 25 (OH) 2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. The Journal of steroid biochemistry and molecular biology. 2007 Mar 1;103(3-5):533-7.
Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. American Journal of Physiology-Endocrinology and Metabolism. 1990 Jan 1;258(1):E134-42.
Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochemical and biophysical research communications. 2015 Jan 9;456(2):631-6.
Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC. 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. Journal of Biological Chemistry. 2007 Oct 12;282(41):29821-30.
Vickers NJ. Animal communication: when i’m calling you, will you answer too?. Current biology. 2017 Jul 24;27(14):R713-5.
Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. The American journal of clinical nutrition. 2008 Jan 1;87(1):136-41.
Hintzpeter B, Mensink GB, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. European journal of clinical nutrition. 2008 Sep;62(9):1079-89.
Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, insulin-like growth factor 1 and metabolic syndrome at age 45y: a cross-sectional study in the 1958 British birth cohort. Diabetes. 2007 Nov 12.
Neves JP, Silva AS, Morais LC, Diniz AD, Costa MJ, Asciutti LS, Gonçalves MD. Concentrações de 25-hidroxivitamina D e níveis pressóricos em idosos hipertensos. Arquivos Brasileiros de Endocrinologia & Metabologia. 2012 Oct;56(7):415-22.
van Ballegooijen AJ, Kestenbaum B, Sachs MC, de Boer IH, Siscovick DS, Hoofnagle AN, Ix JH, Visser M, Brouwer IA. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology. 2014 Apr 1;63(12):1214-22.
Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Silljé HH, van Gilst WH, Jaarsma T, de Boer RA. Vitamin D status and outcomes in heart failure patients. European journal of heart failure. 2011 Jun;13(6):619-25.
Murr C, Pilz S, Grammer TB, Kleber ME, Meinitzer A, Boehm BO, März W, Fuchs D. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clinical Chemistry and Laboratory Medicine (CCLM). 2012 Dec 1;50(12):2205-12.
Ronco C, Ronco F. Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart failure reviews. 2012 Mar 1;17(2):151-60.
Sun Y, Zhang J, Zhang JQ, Ramires FJ. Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats. Hypertension. 2000 May;35(5):1078-84.
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney international. 2007 Jan 1;71(1):31-8.
McMurray JJ. Systolic heart failure. New England Journal of Medicine. 2010 Jan 21;362(3):228-38.
Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P. Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012;122(1):23-35.
Milazzo V, De Metrio M, Cosentino N, Marenzi G, Tremoli E. Vitamin D and acute myocardial infarction. World journal of cardiology. 2017 Jan 26;9(1):14.
Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB, Group IH. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. The American journal of cardiology. 2010 Oct 1;106(7):963-8.
Aleksova A, Belfiore R, Carriere C, Kassem S, La Carrubba S, Barbati G, Sinagra G. Vitamin D deficiency in patients with acute myocardial infarction: an Italian single-center study. Int J Vitam Nutr Res. 2015 Jan 1;85(1-2):23-30.
Lund B, Badskjaer J, Lund BJ, Soerensen OH. Vitamin D and ischaemic heart disease. Hormone and Metabolic Research. 1978 Nov;10(06):553-6.
Lee JH, Gadi R, Spertus JA, Tang F, O'Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. The American journal of cardiology. 2011 Jun 1;107(11):1636-8.
Dziedzic EA, Gąsior JS, Pawłowski M, Dąbrowski M. Association of vitamin D deficiency and degree of coronary artery disease in cardiac patients with type 2 diabetes. Journal of diabetes research. 2017 Jan 1;2017.
Roy A, Lakshmy R, Tarik M, Tandon N, Reddy KS, Prabhakaran D. Independent association of severe vitamin D deficiency as a risk of acute myocardial infarction in Indians. Indian heart journal. 2015 Jan 1;67(1):27-32.
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of internal medicine. 2008 Jun 9;168(11):1174-80.
Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arteriosclerosis, thrombosis, and vascular biology. 2012 Nov;32(11):2794-802.
Aleksova A, Belfiore R, Carriere C, Kassem S, La Carrubba S, Barbati G, Sinagra G. Vitamin D deficiency in patients with acute myocardial infarction: an Italian single-center study. Int J Vitam Nutr Res. 2015 Jan 1;85(1-2):23-30.
De Metrio M, Milazzo V, Rubino M, Cabiati A, Moltrasio M, Marana I, Campodonico J, Cosentino N, Veglia F, Bonomi A, Camera M. Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective study. Medicine. 2015 May;94(19).
Glueck CJ, Jetty V, Rothschild M, Duhon G, Shah P, Prince M, Lee K, Goldenberg M, Kumar A, Goldenberg N, Wang P. Associations between serum 25-hydroxyvitamin D and lipids, lipoprotein cholesterols, and homocysteine. North American journal of medical sciences. 2016 Jul;8(7):284.
Gupta GK, Agrawal T, Rai V, Del Core MG, Hunter III WJ, Agrawal DK. Vitamin D supplementation reduces intimal hyperplasia and restenosis following coronary intervention in atherosclerotic swine. PloS one. 2016 Jun 6;11(6):e0156857.
Satilmis S, Celik O, Biyik I, Ozturk D, Celik KA, Akın F, Ayca B, Yalcin B, Dagdelen S. Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population. Bosnian journal of basic medical sciences. 2015 Feb;15(1):67.
Tokarz A, Kusnierz-Cabala B, Kuźniewski M, Gacoń J, Mazur-Laskowska M, Stępień EŁ. Seasonal effect of vitamin D deficiency in patients with acute myocardial infarction. Kardiologia Polska (Polish Heart Journal). 2016;74(8):786-92.
Gondim F, Caribé A, Vasconcelos KF, Segundo AD, Bandeira F. Vitamin D deficiency is associated with severity of acute coronary syndrome in patients with type 2 diabetes and high rates of sun exposure. Clinical Medicine Insights: Endocrinology and Diabetes. 2016 Jan;9:CMED-S39427.
Eren E, Ellidag HY, Yılmaz A, Aydın Ö, Yılmaz N. No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome. Advances in medical sciences. 2015 Mar 1;60(1):89-93.
Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. International journal of epidemiology. 2015 Apr 1;44(2):651-61.
Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of internal medicine. 2007 Jun 11;167(11):1159-65.
Chung PW, Park KY, Kim JM, Shin DW, Park MS, Chung YJ, Ha SY, Ahn SW, Shin HW, Kim YB, Moon HS. 25-hydroxyvitamin D status is associated with chronic cerebral small vessel disease. Stroke. 2015 Jan;46(1):248-51.
Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M. Women’s Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007 Feb 20;115(7):846-54.
Wu L, Sun D. Effects of calcium plus vitamin D supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Journal of Human Hypertension. 2017 Sep;31(9):547-54.
Gotsman I, Shauer A, Zwas DR, Hellman Y, Keren A, Lotan C, Admon D. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. European journal of heart failure. 2012 Apr;14(4):357-66.
Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. International journal of cardiology. 2013 Oct 30;169(2):106-11.
Narasimhan S, Balasubramanian P. Role of vitamin D in the outcome of ischemic stroke-a randomized controlled trial. Journal of clinical and diagnostic research: JCDR. 2017 Feb;11(2):CC06.
Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, MacFadyen JG, Danielson E, Lin J, Zhang SM. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary clinical trials. 2012 Jan 1;33(1):159-71.
Pradhan AD, Manson JE. Update on the Vitamin D and OmegA-3 trial (VITAL). The Journal of steroid biochemistry and molecular biology. 2016 Jan 1;155:252-6.
Le TY, Ogawa M, Kizana E, Gunton JE, Chong JJ. Vitamin D improves cardiac function after myocardial infarction through modulation of resident cardiac progenitor cells. Heart, Lung and Circulation. 2018 Aug 1;27(8):967-75.
Yin K, You Y, Swier V, Tang L, Radwan MM, Pandya AN, Agrawal DK. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine. Arteriosclerosis, thrombosis, and vascular biology. 2015 Nov;35(11):2432-42.
Xiang W, Hu ZL, He XJ, Dang XQ. Intravenous transfusion of endothelial progenitor cells that overexpress vitamin D receptor inhibits atherosclerosis in apoE-deficient mice. Biomedicine & Pharmacotherapy. 2016 Dec 1;84:1233-42.
El-Fakhri N, McDevitt H, Shaikh MG, Halsey C, Ahmed SF. Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Hormone research in paediatrics. 2014;81(6):363-78.
Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, Isbel NM. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA internal medicine. 2015 May 1;175(5):745-54.
Legarth C, Grimm D, Krüger M, Infanger M, Wehland M. Potential beneficial effects of vitamin d in coronary artery disease. Nutrients. 2020 Jan;12(1):99.
Legarth C, Grimm D, Wehland M, Bauer J, Krüger M. The impact of vitamin D in the treatment of essential hypertension. International journal of molecular sciences. 2018 Feb;19(2):455.
Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, Grimnes G, Gudnason V, Lips P, Pilz S, Van Schoor NM. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017 Jul 7;12(7):e0180512.
Beveridge LA, Khan F, Struthers AD, Armitage J, Barchetta I, Bressendorff I, Cavallo MG, Clarke R, Dalan R, Dreyer G, Gepner AD. Effect of vitamin D supplementation on markers of vascular function: a systematic review and individual participant meta‐analysis. Journal of the American Heart Association. 2018 May 30;7(11):e008273.
Abbasi F, Feldman D, Caulfield MP, Hantash FM, Reaven GM. Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension. American journal of hypertension. 2015 Feb 1;28(2):266-72.
McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Annals of internal medicine. 2011 Dec 20;155(12):820-6.
Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. American journal of hypertension. 2011 Mar 1;24(3):253-62.
Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF. Vitamin D, cardiovascular disease and mortality. Clinical endocrinology. 2011 Nov;75(5):575-84.
Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease: will it live up to its hype?. Journal of the American College of Cardiology. 2011 Oct 4;58(15):1547-56.
Wuerzner G, Burnier M, Waeber B. Should hypertensive patients take vitamin D?. Current hypertension reports. 2012 Aug 1;14(4):318-23.
Brandenburg VM, Vervloet MG, Marx N. The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis. 2012 Dec 1;225(2):253-63.
Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD, Giaccari AN. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutrition, Metabolism and Cardiovascular Diseases. 2012 Feb 1;22(2):81-7.
Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocrine reviews. 2012 Jun 1;33(3):456-92.
Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Current opinion in nephrology and hypertension. 2012 Sep 1;21(5):492-9.
Kienreich K, Grübler M, Tomaschitz A, Schmid J, Verheyen N, Rutters F, Dekker JM, Pilz S. Vitamin D, arterial hypertension & cerebrovascular disease. The Indian journal of medical research. 2013 Apr;137(4):669.
Liu ZM, Woo J, Wu SH, Ho SC. The role of vitamin D in blood pressure, endothelial and renal function in postmenopausal women. Nutrients. 2013 Jul;5(7):2590-610.
Min B. Effects of vitamin D on blood pressure and endothelial function. The Korean Journal of Physiology & Pharmacology. 2013 Oct 1;17(5):385-92.
Rostand SG. Vitamin D deficiency in the pathogenesis of hypertension: still an unsettled question. Current hypertension reports. 2014 Aug 1;16(8):464.
Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, Balercia G, Kimball S, Kotsa K, Mascitelli L, Bhattoa HP. Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke. International journal of cardiology. 2017 Mar 1;230:577-84.
Wang TJ. Vitamin D and cardiovascular disease. Annual review of medicine. 2016 Jan 14;67:261-72.
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of internal medicine. 2008 Jun 9;168(11):1174-80.
Judd S, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Circulation. 2008 Jan 29;117(4):503.
Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. The Journal of Clinical Endocrinology & Metabolism. 2008 Oct 1;93(10):3927-35.
Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. The Journal of nutrition. 2006 Nov 1;136(11):2754-9.
DOI: https://doi.org/10.37591/rrjom.v11i2.2590
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Research & Reviews: Journal of Medicine